# Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)

> **NCT01352650** · PHASE1 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 71 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** plerixafor
- **DRUG:** decitabine

## Key facts

- **NCT ID:** NCT01352650
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-17
- **Primary completion:** 2016-12-27
- **Final completion:** 2016-12-27
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352650, "Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01352650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*